Restrictive Lung DiseasesArchives
Clinical analysis of patients with idiopathic pulmonary fibrosis concurrent with surgery resectable lung cancer: a retrospective cohort study from perspective of ILD physicians
Restrictive Lung Diseases 5 min.
The use of antifibrotic medications improve transplantation-free survival in patients with idiopathic pulmonary fibrosis (IPF) [1]. Owing to prolonged survival, comorbidities have become a source of concern for IPF patients. Among these comorbidities, lung cancer is a common potentially fatal comorbidity...
Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease
Restrictive Lung Diseases 6 min.
Interstitial lung diseases (ILDs), characterized by varying degrees of inflammation and fibrosis, are a heterogeneous group of parenchymal pulmonary disorders [1, 2]. Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) exhibit progressive fibrosis, which leads to a decline in...
Dehydrocorydaline attenuates bleomycin-induced pulmonary fibrosis by inhibiting fibroblast activation
Restrictive Lung Diseases 7 min.
Pulmonary fibrosis (PF) represents a type of interstitial lung disease characterized by the irreversible degradation of alveolar architecture and the abnormal deposition of extracellular matrix resulting in impaired gas exchange and respiratory failure [1, 2–3]. Unfortunately, the two FDA-approved...
Associations of peripheral blood lymphopenia to disease course, treatment and TNF-α in sarcoidosis
Restrictive Lung Diseases 5 min.
The clinical presentation of the inflammatory systemic disease sarcoidosis is variable. Virtually any organ can be affected, but the lungs and/or intrathoracic lymph nodes are engaged in most cases. Patients with Löfgren’s syndrome (LS) experience an acute and often self-limiting disease,...
